Literature DB >> 24370359

[Relationship between AKAP95, cyclin E1, cyclin D1, and clinicopathological parameters in lung cancer tissue].

Su-xian Hu1, Xiang-yu Kong, Yang-yang Yuan, Bo-gang Teng, Xue-hong Zhi, Wen-xin Zhuang, Xiu-yi Yu, Wen-zhi Liu, Yong-xing Zhang2.   

Abstract

OBJECTIVE: To investigate the correlation between expression of A-kinase anchoring protein 95 (AKAP95) and protein expression of cyclin E1 and cyclin D1 in lung cancer tissue.
METHODS: Fifty-one cases of lung cancer were included in the study. The protein expression of AKAP95, cyclin E1, and cyclin D1 were measured by immunohistochemistry.
RESULTS: The protein expression of cyclin E1 in lung cancer tissues was significantly higher than that in para-cancerous tissues (positive rate: 75.56%vs 20%, P < 0.01); its expression showed no relationship with histopathological type, lymph node metastasis, and cellular differentiation (P > 0.05). The protein expression of cyclin D1 in lung cancer tissues was higher than that in para-cancerous tissues (positive rate: 69.39% vs 14.29%); its expression showed a significant relationship with histopathological type (P < 0.05). The expression of AKAP95 was correlated with the protein expression of cyclin E1 and cyclin D1 in lung cancer tissues (P < 0.01).
CONCLUSION: Cyclin E1 and cyclin D1 are highly expressed in lung cancer tissue, suggesting that they play an important role in the development and progression of lung cancer. The protein expression of cyclin E1 has no relationship with cellular differentiation, lymph node metastasis, and histopathological type of lung cancer, and the protein expression of cyclin D1 has a significant relationship with histopathological type. The expression of AKAP95 is correlated with the protein expression of cyclin E1 and cyclin D1 in lung cancer tissue.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24370359

Source DB:  PubMed          Journal:  Zhonghua Lao Dong Wei Sheng Zhi Ye Bing Za Zhi        ISSN: 1001-9391


  5 in total

1.  Synergistic effects of AKAP95, Cyclin D1, Cyclin E1, and Cx43 in the development of rectal cancer.

Authors:  Fengjie Qi; Yangyang Yuan; Xuehong Zhi; Qian Huang; Yuexin Chen; Wenxin Zhuang; Dengcheng Zhang; Bogang Teng; Xiangyu Kong; Yongxing Zhang
Journal:  Int J Clin Exp Pathol       Date:  2015-02-01

2.  AKAP95 promotes cell cycle progression via interactions with cyclin E and low molecular weight cyclin E.

Authors:  Xiang-Yu Kong; Deng-Cheng Zhang; Wen-Xin Zhuang; Su-Hang Hua; Yue Dai; Yang-Yang Yuan; Li-Li Feng; Qian Huang; Bo-Gang Teng; Xiu-Yi Yu; Wen-Zhi Liu; Yong-Xing Zhang
Journal:  Am J Transl Res       Date:  2016-02-15       Impact factor: 4.060

3.  Correlation between the protein expression of A-kinase anchor protein 95, cyclin D3 and AKT and pathological indicators in lung cancer tissues.

Authors:  Xiuyi Yu; Yangyang Yuan; Xuehong Zhi; Bogang Teng; Xiaoxuan Chen; Qian Huang; Yuexin Chen; Zhiyu Guan; Yongxing Zhang
Journal:  Exp Ther Med       Date:  2015-07-15       Impact factor: 2.447

4.  Expression of AKAP95, Cx43, CyclinE1 and CyclinD1 in esophageal cancer and their association with the clinical and pathological parameters.

Authors:  Shupeng Zhao; Min Yi; Yangyang Yuan; Wenxin Zhuang; Dengcheng Zhang; Xiuyi Yu; Xiaoxuan Chen; Bogang Teng; Zhiyu Guan; Yongxing Zhang
Journal:  Int J Clin Exp Med       Date:  2015-05-15

5.  Dynamic changes in protein interaction between AKAP95 and Cx43 during cell cycle progression of A549 cells.

Authors:  Xiaoxuan Chen; Xiangyu Kong; Wenxin Zhuang; Bogang Teng; Xiuyi Yu; Suhang Hua; Su Wang; Fengchao Liang; Dan Ma; Suhui Zhang; Xuan Zou; Yue Dai; Wei Yang; Yongxing Zhang
Journal:  Sci Rep       Date:  2016-02-16       Impact factor: 4.379

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.